0001477932-21-003653.txt : 20210527 0001477932-21-003653.hdr.sgml : 20210527 20210527194019 ACCESSION NUMBER: 0001477932-21-003653 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180101 FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Udell Mark CENTRAL INDEX KEY: 0001490433 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55908 FILM NUMBER: 21975196 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp. CENTRAL INDEX KEY: 0001643301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371765151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805-824-0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 FORMER COMPANY: FORMER CONFORMED NAME: Makkanotti Group Corp. DATE OF NAME CHANGE: 20150526 4 1 form4.xml FORM 4 X0306 4 2018-01-01-05:00 false 0001643301 Cure Pharmaceutical Holding Corp. CURR 0001490433 Udell Mark 1620 BEACON PLACE OXNARD CA 93033 false true false false Chief Accounting Officer Stock Option 0.74 2018-01-01-05:00 4 A false 150000 0.00 A 2028-04-06-05:00 Common Stock 150000 150000 D The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person. /s/ Mark Udell 2021-05-27-05:00